Literature DB >> 25615808

Diagnosis and treatment for ocular tuberculosis among uveitis specialists: the international perspective.

Susan M Lou1, Paul A Montgomery, Kelly L Larkin, Kevin Winthrop, Manfred Zierhut, James T Rosenbaum.   

Abstract

PURPOSE: To assess the approach of international specialists, who primarily practice in tuberculosis-endemic areas, to ocular tuberculosis (TB).
METHODS: International experts from India, Brazil, Taiwan, and more than 10 other countries were surveyed using two clinical cases and general questions.
RESULTS: A total of 244 experts were sent a survey about the treatment and diagnosis of ocular tuberculosis; 65 responded (27%), of whom 34 were affiliated with practices in India, while 31 primarily practice at international sites outside of India and North America. The data from this survey were compared with the results of a similar survey sent to members of the American Uveitis Society. The survey provided normative data on how physicians evaluate patients with uveitis as well as opinions about ocular TB. Responses varied widely on topics such as tests to include in the workup of undifferentiated uveitis, initial therapy, and duration of treatment. Physicians from developing countries relied more on chest CT scans and tuberculin skin testing (TST) than their counterparts in developed countries.
CONCLUSIONS: The approach to diagnosis and management of TB is heterogeneous worldwide. However, there are substantial differences in the clinical approach to uveitis depending on the clinician's location of practice.

Entities:  

Keywords:  Diagnostic criteria; international; post-test probability; pretest probability; treatment; tuberculosis; uveitis

Mesh:

Substances:

Year:  2015        PMID: 25615808     DOI: 10.3109/09273948.2014.994784

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  7 in total

1.  Dysregulated expression of microRNAs in aqueous humor from intraocular tuberculosis patients.

Authors:  Swathi Chadalawada; Kandasamy Kathirvel; Prajna Lalitha; S R Rathinam; Bharanidharan Devarajan
Journal:  Mol Biol Rep       Date:  2021-10-22       Impact factor: 2.316

2.  Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1.

Authors:  Rupesh Agrawal; Dinesh Visva Gunasekeran; Robert Grant; Aniruddha Agarwal; Onn Min Kon; Quan Dong Nguyen; Carlos Pavesio; Vishali Gupta
Journal:  JAMA Ophthalmol       Date:  2017-12-01       Impact factor: 7.389

3.  Contribution of Dual Fluorescein and Indocyanine Green Angiography to the Appraisal of Presumed Tuberculous Chorioretinitis in a Non-endemic Area.

Authors:  Raphael Massy; Carl P Herbort
Journal:  J Ophthalmic Vis Res       Date:  2017 Jan-Mar

4.  Program-wide review and follow-up of erythema Induratum of Bazin and tuberculosis-associated ocular inflammation management in a TB low-incidence setting: need for improved treatment candidate selection, therapy standardization, and care collaboration.

Authors:  William J Connors; Dina A Fisher; Dennis Y Kunimoto; Julie M Jarand
Journal:  BMC Infect Dis       Date:  2019-01-29       Impact factor: 3.090

Review 5.  BTS clinical statement for the diagnosis and management of ocular tuberculosis.

Authors:  Onn Min Kon; Nicholas Beare; David Connell; Erika Damato; Thomas Gorsuch; Guy Hagan; Felicity Perrin; Harry Petrushkin; Jessica Potter; Charanjit Sethi; Miles Stanford
Journal:  BMJ Open Respir Res       Date:  2022-03

6.  Clinical and Epidemiological Study on Tubercular Uveitis in a Tertiary Eye Care Centre in Italy.

Authors:  M La Cava; A Bruscolini; M Sacchetti; M P Pirraglia; A Moramarco; M Marenco; G Iaiani; G Covelli; T Rizzo; I Abicca; A Lambiase
Journal:  J Ophthalmol       Date:  2020-03-14       Impact factor: 1.909

7.  Clinical Manifestations and Outcomes of Tubercular Uveitis in Taiwan-A Ten-Year Multicenter Retrospective Study.

Authors:  Chun-Ju Lin; Ning-Yi Hsia; De-Kuang Hwang; Yih-Shiou Hwang; Yo-Chen Chang; Yueh-Chang Lee; Yung-Ray Hsu; Po-Ting Yeh; Chang-Ping Lin; Hsi-Fu Chen; Wei-Chun Jan; Wei-Yu Chiang; Ming-Ling Tsai
Journal:  Medicina (Kaunas)       Date:  2022-03-03       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.